Cyxone AB Cash Flow From Operations vs. Number Of Employees
| CYXO Stock | SEK 0.03 0.01 21.57% |
For Cyxone AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cyxone AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cyxone AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cyxone AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cyxone AB over time as well as its relative position and ranking within its peers.
Cyxone |
Cyxone AB Number Of Employees vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cyxone AB's current stock value. Our valuation model uses many indicators to compare Cyxone AB value to that of its competitors to determine the firm's financial worth. Cyxone AB is number one stock in cash flow from operations category among its peers. It is rated second in number of employees category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cyxone AB's earnings, one of the primary drivers of an investment's value.Cyxone Number Of Employees vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Cyxone AB |
| = | (43.25 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Cyxone AB |
| = | 8 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Cyxone Number Of Employees vs Competition
Cyxone AB is rated second in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 293. Cyxone AB holds roughly 8.0 in number of employees claiming about 2.73% of stocks in Biotechnology industry.
Cyxone AB Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cyxone AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cyxone AB will eventually generate negative long term returns. The profitability progress is the general direction of Cyxone AB's change in net profit over the period of time. It can combine multiple indicators of Cyxone AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. Cyxone AB is traded on Stockholm Stock Exchange in Sweden.
Cyxone Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cyxone AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cyxone AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cyxone AB's important profitability drivers and their relationship over time.
Use Cyxone AB in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyxone AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyxone AB will appreciate offsetting losses from the drop in the long position's value.Cyxone AB Pair Trading
Cyxone AB Pair Trading Analysis
The ability to find closely correlated positions to Cyxone AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyxone AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyxone AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyxone AB to buy it.
The correlation of Cyxone AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyxone AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyxone AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyxone AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Cyxone AB position
In addition to having Cyxone AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cyxone Stock Analysis
When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.